Navigation Links
Radiologists attempt to solve mystery of Tut's demise

Egyptian radiologists who performed the first-ever computed tomography (CT) evaluation of King Tutankhamun’s mummy believe they have solved the mystery of how the ancient pharaoh died. The CT images and results of their study were presented today at the annual meeting of the Radiological Society of North America (RSNA).

Ashraf Selim, M.D., radiologist at Kasr Eleini Teaching Hospital, Cairo University in Egypt, was part of an international team of scientists that studied the 3,300-year-old mummy of King Tut in Egypt. Using a mobile multi-detector CT scanner, the researchers performed a full-body scan on the king's remains, obtaining approximately 1,900 digital cross-sectional images.

"We found the mummy was in a critical stage of preservation," said Dr. Selim. "The body was cut into several parts with some missing pieces."

With the help of the CT images, researchers estimated King Tut's age at death to be between 18 and 20 years. His height was 180 centimeters or approximately 5 feet 11 inches. The researchers discovered a possible premortem fracture to the femoral (thigh) bone. While they cannot assess how the injury occurred, the findings suggest that the injury may have been an open wound that became infected and ultimately fatal.

Since King Tut was first examined by x-ray in 1968, revealing what appeared to be a bone fragment in his skull, it has been widely speculated that a blow to the head killed the boy king. However, Dr. Selim and colleagues found several pieces of evidence to the contrary. In the cranial cavity, they found loose bone fragments that were not covered with the intracranial solidified embalming material. These bone fragments matched exactly a defect within the first vertebra in the neck. They found no evidence of skull fractures.

A mishap during the mummification process, or even damage incurred during that first x-ray examination may explain the misplaced—and misleading—bone fragments. Dr. Seli
'"/>

Source:Radiological Society of North America


Page: 1 2

Related biology news :

1. Tiny particles could solve billion-dollar problem
2. Scientists solve structure of key protein in innate immune response
3. Could microbes solve Russias chemical weapons conundrum?
4. Brown-Harvard team solves mobile DNAs surgical sleight-of-hand
5. Scripps research scientists solve structure of a critical innate immune system protein
6. Unweaving amyloid fibers to solve prion puzzles
7. Sperm trading can resolve hermaphrodite mating conflicts
8. Bees solve complex colour puzzles
9. Researchers solve mystery of how nuclear pores duplicate before cell division
10. Mystery solved: Golds power against autoimmune diseases defined
11. One big biology question solved

Post Your Comments:
(Date:12/1/2009)...Ben-Ari, winner of the 2009 Inserm Grand Prix., ...mitment to paying tribute to outstanding,work per...ouring talents, Inserm intends to,demonstrate the...day,s biological, medical and,health research, an...who carry out and,drive this research each day. T...
(Date:12/1/2009)...LE, Fla. Hit-and-run attacks by sharks can be sol...its by the unique chomp they put on their victims,...nd shark expert. , In a method analogous to anal...tifications by precisely comparing shark bites to ... George Burgess, director of the International Sha...
(Date:12/1/2009)...d first, a Monash University-led international res...t the output of the next generation of solar cells...ation with colleagues from the universities of Wol...ye-sensitised solar cells with a three-fold increa...reviously reported tandem dye-sensitised solar cel...
Breaking Biology News(10 mins):Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Innovation puts next-generation solar cells on the horizon 2Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 1Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 2VisionDirect com Offers Contact Lens Customers a New Way to Pay 48307 1VisionDirect com Offers Contact Lens Customers a New Way to Pay 48307 2VisionDirect com Offers Contact Lens Customers a New Way to Pay 48307 3Accumetrics Inc Announces Distribution Channels in Israel and Cyprus 48302 1Accumetrics Inc Announces Distribution Channels in Israel and Cyprus 48302 2
...w research shows that we should be looking to the ...ould have its most perilous impact on life on Eart...borough have published research findings in the pr...global warming actually changes the molecular stru...s more than twice the amount of carbon than does t...
...new study by Narendra et al. suggests that Parkin,...ne Park2, prompts neuronal survival by clearing th... an exciting new discovery that links the fields o...f Parkinson,s disease (PD)," writes Heidi McBride ... work significantly increases our understanding of...
...lacksburg, Va. An international consortium of res...e of the domesticated turkey, Meleagris gallopavo....che GS-FLX sequencing platform and the recently la... and reagents. , The new upgrade to the Roche GS... individual sequencing reads to be generated for e...
Other Biology News:Global warming is changing organic matter in soil 2Research consortium to sequence turkey genome 2Research consortium to sequence turkey genome 3Research consortium to sequence turkey genome 4
(Date:12/1/2009)...NCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-FirstCall...day announced revenue guidance for the fourth quar...illion, as compared with $69 million for the fourt... results was the first of two installment payments...fourth quarter 2008 results was a one-time $1.8 mi...
(Date:12/1/2009)... , CAMBRIDGE, Mass., Dec. 1 To...dustry and to promote its potential, a group of in... the Synthetic Biology Industry Association (SynBI... of the association is to provide a forum for indi...w industry, address its opportunities and its chal...
(Date:12/1/2009)...SAN FRANCISCO, Dec. 1 The Burrill ...alf the value it lost in October. The Select,s gai...nt month for the general markets with the Dow up 6... The gains held firm in the final two trading days...ish Thanksgiving holiday shopping and Dubai,s repo...
(Date:12/1/2009)... , SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ ...) announced today that it will present at the LD M...:00 p.m. (PST) at the Luxe Hotel in Los Angeles. A... will present a corporate overview and will provid... its lead product, the Hemopurifier®, a first...
Breaking Biology Technology:PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2
.... 29 Allos,Therapeutics, Inc. (Nasdaq: ALTH ), a...ent and commercialization of small molecule therap...d that members of the Company,s,senior management ...ill,Lynch Global Pharmaceutical, Biotechnology and...any,s presentation will take place at 11:00 a.m. (...
...swire/ - Viventia Biotech Inc., a privately held,b...novel antibody,therapeutics focused on cancer, ann...natives to further advance and realize value from ...dy discovery platform and its,antibody manufacturi...al,strategic opportunities including, but not limi...
...to Canadian HAI Market; Market Expenditures for MR...llion by 2012, SUNNYVALE, Calif., Jan. 29 Cephei...a has issued a medical device,license for the Xper...llin,Resistant Staphylococcus aureus (MRSA) on nas...est results are available in approximately 70 minu...
Other Biology Technology:Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference 2Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 2Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 3Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 4Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 5Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 6Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 2Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 3Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 4
...uct has been developed to significantly increase t...ns. Stability is increased at room temperature st...his product is subjected to 0.45 micron filtration...ion insures consistently high levels of activity f...
...atic I provides a convenient and affordable altern... Used with an eight-port disposable manifold, the ...ible with multi-channel pipettes. The eight-port m...s fluids in volumes of 100, 200, 250, or 300mL wit...
Corning brand cover glass squares, 0.16 to 0.19mm thick from Sigma-Aldrich
...ilm Life Science FLA-8000 Fluorescent Image Analyz...ection in a single laser imaging system. This powe...labeled with fluorescent dyes or radioisotopes at ...g laboratories. Speed, image quality and flexibili...
Biology Products: